Robert Barrow, Chief Executive Officer at Mind Medicine (MindMed) Inc. (MNMD), sold 38,212 shares at $7.43 ($284K) on 2024-12-26, disclosed to the SEC on 2024-12-27.
Scheduled sale ($284k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.43 | 19,106 | $142K | 50.0% |
| 2 | $7.43 | 19,106 | $142K | 50.0% |
| Total | $7.43 avg | 38,212 | $284K | 100% |
| Filing → |
| DFTX | SELL | 2026-06-26 | $1.3M | — | Filing → |
| DFTX | SELL | 2026-03-26 | $451K | — | Filing → |
| MNMD | SELL | 2025-12-29 | $678K | — | Filing → |